Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
319,078,349
-
Share change
-
-8,983,261
-
Total reported value
-
$12,705,963,590
-
Put/Call ratio
-
60%
-
Price per share
-
$39.82
-
Number of holders
-
781
-
Value change
-
-$351,544,014
-
Number of buys
-
349
-
Number of sells
-
313
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q2 2021
As of 30 Jun 2021 GLAXOSMITHKLINE PLC - ADR (GSK) had 781 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 319,078,349 shares of stock of the company.
Largest 10 holders included Dodge & Cox, Capital International Investors, Fisher Asset Management, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, STATE STREET CORP, Black Creek Investment Management Inc., RENAISSANCE TECHNOLOGIES LLC, and UBS Group AG.
This table shows 789 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.